Nicolas Vaux-Montagny

Latest in Operations
Today in Manufacturing Podcast
Sponsored
Today in Manufacturing Podcast
November 11, 2024
CEO Stellantis Carlos Tavares speaks during the Paris Automotive Summit on the sideline of the Paris Auto Show, in Paris, Oct. 15, 2024.
Stellantis CEO Carlos Tavares Steps Down
December 2, 2024
Intel CEO Pat Gelsinger speaks while holding a new chip, called Gaudi 3, during an event called AI Everywhere in New York, on Dec. 14, 2023.
Intel CEO Gelsinger Retires
December 2, 2024
L3Harris Technologies Facility in Burlington, Ontario, Canada.
U.S. Navy Awards L3Harris Nearly $1 Billion Communication Technology Contract
November 26, 2024
Related Stories
Don't upset your grandmother.
Operations
7 Thanksgiving Mistakes People Still Make
A worker lays a cable at a home building site in Flowood, Miss. on Sept. 23, 2021.
Operations
Small Business Owners Breathe Easier Over Labor Costs After Decision to Strike Down Overtime Rule
Manufacturing
Operations
Projections in a Time of Uncertainty
Today in Manufacturing Podcast
Sponsor Content
Today in Manufacturing Podcast
More from Nicolas Vaux-Montagny
Today in Manufacturing Podcast
Sponsored
Today in Manufacturing Podcast
Today in Manufacturing has a new podcast brought to you by the editors of Industrial Media. In each episode, we discuss the five biggest stories in manufacturing, and the implications they have on the industry moving forward.
November 11, 2024
In this May 21, 2013 file photo, Jacques Servier, founder of Servier Laboratories, sits during the opening of the trial of the so-called Mediator case, a drug linked to hundreds of deaths, at Nanterre's court house, outside Paris. A massive trial with more than 4,000 plaintiffs is opening for French pharmaceutical giant Servier Laboratoires and France's medicines watchdog, accused of involuntary manslaughter, fraud and other charges in a scandal over a diabetes medication suspected of causing hundreds of deaths.
Regulation
Major Trial Opens Over Diet-Pills
Although designed as a diabetes drug, Mediator was widely prescribed as a hunger suppressant to millions of people before sales were suspended in France in 2009.
September 23, 2019